Melinta Subsidiary Corp. (extinct)

Melinta Subsidiary Corp. (extinct)

Melinta Subsidiary Corp. (extinct)

Overview
Date Founded

2000

Headquarters

300 George Street Suite 301 New Haven CT 06511

Type of Company

Private

Industries

Pharmaceuticals

Company Description

Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT.

In The News
Executives & Employees

Co-Founder

Paths to Melinta Subsidiary Corp.
Potential Connections via
Relationship Science
You
Melinta Subsidiary Corp.
Recent Transactions
Details Hidden

Cempra, Inc. purchases Melinta Subsidiary Corp. from Warburg Pincus LLC, Connecticut Innovations, Inc., Oxford Bioscience Partners, GSK Equity Investments Ltd, Cardinal Partners, ABS Ventures, EuclidSR Partners, Saints Ventures LLC, Axiom Venture Partners

Details Hidden

Melinta Subsidiary Corp. raised money in a private placement transaction

Details Hidden

Melinta Subsidiary Corp. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onCempra, Inc. purchases Melinta Subsidiary Corp. from Warburg Pincus LLC, Connecticut Innovations, Inc., Oxford Bioscience Partners, GSK Equity Investments Ltd, Cardinal Partners, ABS Ventures, EuclidSR Partners, Saints Ventures LLC, Axiom Venture Partners

Legal Advisor

Advised onCempra, Inc. purchases Melinta Subsidiary Corp. from Warburg Pincus LLC, Connecticut Innovations, Inc., Oxford Bioscience Partners, GSK Equity Investments Ltd, Cardinal Partners, ABS Ventures, EuclidSR Partners, Saints Ventures LLC, Axiom Venture Partners

Associate

Advised onCempra, Inc. purchases Melinta Subsidiary Corp. from Warburg Pincus LLC, Connecticut Innovations, Inc., Oxford Bioscience Partners, GSK Equity Investments Ltd, Cardinal Partners, ABS Ventures, EuclidSR Partners, Saints Ventures LLC, Axiom Venture Partners

Associate

Advised onCempra, Inc. purchases Melinta Subsidiary Corp. from Warburg Pincus LLC, Connecticut Innovations, Inc., Oxford Bioscience Partners, GSK Equity Investments Ltd, Cardinal Partners, ABS Ventures, EuclidSR Partners, Saints Ventures LLC, Axiom Venture Partners

Legal Advisor

Advised onCempra, Inc. purchases Melinta Subsidiary Corp. from Warburg Pincus LLC, Connecticut Innovations, Inc., Oxford Bioscience Partners, GSK Equity Investments Ltd, Cardinal Partners, ABS Ventures, EuclidSR Partners, Saints Ventures LLC, Axiom Venture Partners

Advisors & Consultants
Publicist

Professional at Scienta Communications

Non-Profit Donations & Grants
$100 - $500
2010
Investors
Details Hidden

President & Executive Director at The Agouron Institute

Details Hidden

Scientific Founder at Melinta Therapeutics, Inc.

Details Hidden

Entrepreneur-in-Residence at Yale University Office of Cooperative Research

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Melinta Subsidiary Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Melinta Subsidiary Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Melinta Subsidiary Corp..